Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice
Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad
Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad
View: Text | PDF
Research Article Inflammation Neuroscience

Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice

  • Text
  • PDF
Abstract

Surgery can induce cognitive decline, a risk that increases with advancing age. In rodents, postoperative cognitive decline (POCD) is associated with the inflammatory activation of hippocampal microglia. To examine the role of microglia in POCD, we inhibited the colony-stimulating factor 1 receptor (CSF1R) in adult mice, effectively depleting CNS microglia. Surgical trauma (tibial fracture) reduced the ability of mice to remember a conditioned response learned preoperatively, a deficit more pronounced and persistent in mice with diet-induced obesity (DIO). Whereas microglial depletion by itself did not affect learning or memory, perioperative microglial depletion remarkably protected mice, including those with DIO, from POCD. This protection was associated with reduced hippocampal levels of inflammatory mediators, abrogation of hippocampal recruitment of CCR2+ leukocytes, and higher levels of circulating inflammation-resolving factors. Targeting microglia may thus be a viable strategy to mitigate the development of POCD, particularly in those with increased vulnerability.

Authors

Xiaomei Feng, Martin Valdearcos, Yosuke Uchida, David Lutrin, Mervyn Maze, Suneil K. Koliwad

×

Figure 4

Perioperative microglial depletion prevents the inflammatory and cognitive consequences of surgery in mice with DIO.

Options: View larger image (or click on image) Download as PowerPoint
Perioperative microglial depletion prevents the inflammatory and cogniti...
(A) The freezing response to preoperative TFC testing (% of total time) of healthy (chow-fed) controls, mice with DIO, and mice with DIO treated with PLX5622 (PLX), showing no difference between groups. (B) Freezing times measured from the mice in A (% vs. corresponding sham-treated mice) during TFC testing 3 and 7 days after surgery. Whereas the impact of surgery on TFC memory is transient and returnsto sham levels by day 7 in control mice (*P < 0.001 vs. control at day 3), mice with DIO have a more pronounced (*P < 0.001 vs. control at day 3) and persistent ($$P < 0.001 vs. control mice at day 7) memory loss. Perioperative PLX5622 treatment protects mice with DIO from surgery induced memory loss (‡‡P < 0.005 vs. DIO alone at day 7). (C and D) Analysis of LXA4 and IL-6 levels, showing that DIO paradoxicallylowers plasma LXA4 levels that otherwise rise by 3 days after surgery in healthy control mice (C) and potentiates the postoperative (day 3) rise in hippocampal IL-6 levels seen in control mice (D). (E and F) Corresponding measurements from plasma (LXA4) and hippocampus (IL-6), showing that perioperative PLX5622 treatment abolishes the impact of surgery on circulating LXA4 levels in mice with DIO (E) and prevents hippocampal IL-6 levels from rising in mice with DIO (F). All data are from n = 12–19/group and were analyzed by two-way ANOVA (A, C, and D), one-way ANOVA (B), and Student’s t test (E and F); **P < 0.001 for comparisons shown.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts